Cooperation of p53 loss of function and v-Ha-ras in transformation of mouse keratinocyte cell lines

Molecular Carcinogenesis

Volumn 21, Issue 1, 1998, Pages 50-61

  Azzoli, Christopher G ^a   Sagar, Manish ^a   Wu, Anita ^a   Lowry, David ^a   Hennings, Henry ^a   Morgan, David L ^a   Weinberg, Wendy C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Keratinocyte transformation; p53; v Ha ras

Indexed keywords

PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; KERATINOCYTE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NUDE MOUSE; ONCOGENE H RAS; PRIORITY JOURNAL; SKIN CANCER; SKIN CARCINOGENESIS; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL DIVISION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSPLANTATION; EPIDERMIS; FLUORESCENT ANTIBODY TECHNIQUE; GENE DELETION; GENE EXPRESSION REGULATION; GENES, P53; GENES, RAS; KERATINOCYTES; MICE; MICE, NUDE; ULTRAVIOLET RAYS;

ANIMALIA; MUS MUSCULUS; RODENTIA;

EID: 0031885710     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199801)21:1<50::AID-MC7>3.0.CO;2-T     Document Type: Article

References (54)

1. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878, 1994.
2. Ziegler A, Jonason AS, Leffell DJ, et al. Sunburn and p53 in the onset of skin cancer. Nature 372:773-776, 1994.
3. Brash DE, Rudolph JA, Simon JA, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 88:10124-10128, 1991.
4. Nakazawa H, English D, Randell PL, et al. UV and skin cancer: Specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. Proc Natl Acad Sci USA 91:360-364, 1994.
5. Hinds PW, Finlay CA, Quartin RS, et al. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: A comparison of the "hot spot" mutant phenotypes. Cell Growth Differ 1:571-580, 1990.
6. Rall CJ, Van YX, Graeme-Cook F, et al. Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma. Pancreas 12:10-17, 1996.
7. Gazdar AF, Bader S, Hung J, et al. Molecular genetic changes found in human lung cancer and its precursor lesions. Cold Spring Harbor Symp Quant Biol 59:565-572, 1994.
8. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 87:159-170, 1996.
9. Kemp CJ, Donehower LA, Bradley A, Balmain A. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 74:813-822, 1993.
10. Ruggeri B, Caamano J, Goodrow T, et al. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression. Cancer Res 51:6615-6621, 1991.
11. Quintanilla M, Brown K, Ramsden M, Balmain A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322:78-80, 1986.
12. Ha oncogene. Cancer Res 54:5584-5592, 1994.
13. El-Deiry WS, Tokino WS, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825, 1993.
14. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299, 1995.
15. Weintraub H, Hauschka S, Tapscott SJ. The MCK enhancer contains a p53 responsive element. Proc Natl Acad Sci USA 88:4570-4571, 1991.
16. Kastan MB, Zhan Q, EI-Deiry WS, et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587-597, 1992.
17. Caelles C, Helmberg A, Karin M. p53-dependent apoptosis in the absence "of transcriptional activation of p53-target genes. Nature 370:220-223, 1994.
18. Pietenpol JA, Tokino T, Thiagalingam S, EI-Deiry WS, Kinzler KW, Vogelstein B. Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc Natl Acad Sci USA 91:1998-2002, 1994.
19. Donehower LA, Harvey M, Slegle BL, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215-221, 1992.
20. Kawamura H, Strickland JE, Yuspa SH. Association of resistance to terminal differentiation with initiation of carcinogenesis in adult mouse epidermal cells. Cancer Res 45:2748-2752, 1985.
21. Huff CA, Yuspa SH, Rosenthal D. Identification of control elements 3′ to the human keratin 1 gene that regulate cell type and differentiation-specific expression. J Biol Chem 268:377-384, 1993.
22. Martinez J, Georgoff I, Martinez J, Levine AJ. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev 5:151-159, 1991.
23. Michalovitz D, Halevy O, Oren M. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62:671-680, 1990.
24. Glick AB, Weinberg WC, Wu IH, Quan W, Yuspa SH. Transforming growth factor-β1 suppresses genomic instability independent of a G1 arrest, p53 and Rb. Cancer Res 56: 3645-3650, 1996.
25. Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AJ. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol 8:531-539, 1988.
26. Roop DR, Lowy DR, Tambourin PE, et al. An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue. Nature 323:822-824, 1986.
27. Kern SE. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256:827-830, 1992.
28. Hennings H, Robinson VA, Michael DM, Pettit GR, Jung R, Yuspa SH. Development of an in vitro analogue of initiated mouse epidermis to study tumor promoters and antipromoters. Cancer Res 50:4794-4800, 1990.
29. Kulesz-Martin M, Kilkenny AE, Holbrook KA, Digernes V, Yuspa SH. Properties of carcinogen altered mouse epidermal cells resistant to calcium-induced terminal differentiation. Carcinogenesis 4:1367-1377, 1983.
30. Harvey M, Sands AT, Weiss RS, et al. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8:2457-2467, 1993.
31. MacGregor GR, Mogg AE, Burke JF, Caskey CT. Histochemical staining of clonal mammalian cell lines expressing E. coli β galactosidase indicates heterogeneous expression of the bacterial gene. Somat Cell Mol Genet 13:253-265, 1987.
32. Hainaut P, Butcher S, Milner J. Temperature sensitivity for conformation is an intrinsic property of wild-type p53. Br J Cancer 71:227-231, 1995.
33. Selivanova G, Wiman KG. p53: A cell cycle regulator activated by DNA damage. Adv Cancer Res 66:143-180, 1995.
34. Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR, Harris CC. Hepatitis B virus X protien inhibits p55 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA 91: 2230-2234, 1994.
35. val135 wild-type function in transgenic mice. Lab Invest 74:1005-1011, 1996.
36. Harvey M, Vogel H, Morris D, Bradley A, Bernstein A, Donehower LA. A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice. Nat Genet 9:305-311, 1995.
37. Soddu S, Blandino G, Citro G, et al. Wild-type p53 gene expression induces granulocytic differentiation of HL-60 cells. Blood 83:2230-2237, 1994.
38. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352:345-347, 1991.
39. Knippschild U, KolzauT, Deppert W. Cell-specific transcriptional activation of the mdm2-gene by ectopically expressed wild-type form of a temperature-sensitive mutant p53. Oncogene 11:683-690, 1995.
40. Ishizaki K, Ejima Y, Matsunaga T, et al. Increased UV-induced SCEs but normal repair of DNA damage in p53-deficient mouse cells. Int J Cancer 58:254-257, 1994.
41. DeFrank JS, Tang W, Powell SN. p53-null cells are more sensitive to ultraviolet light only in the presence of caffeine. Cancer Res 56:5365-5368, 1996.
42. Devary Y, Gottlieb RA, Smeal T, Karin M. The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell 71:1081-1091, 1992.
43. Dhanwada KR, Dickens M, Neades R, Davis R, Pelling JC. Differential effects of UV-B and UV-C components of solar radiation on MAP kinase signal transduction pathways in epidermal keratinocytes. Oncogene 11:1947-1953, 1995.
44. Jonason AS, Kunala S, Price GJ, et al. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci USA 93:14025-14029, 1996.
45. Berg RJ, van Kranen HJ, Rebel HG, et al. Early p53 alterations in mouse skin carcinogenesis by UVB radiation: Immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells. Proc Natl Acad Sci USA 93:274-278, 1996.
46. Li G, Mitchell DL, Ho VC, Reed JC, Tron VA. Decreased DNA repair but normal apoptosis in ultraviolet-irradiated skin of p53-transgenic mice. Am J Pathol 148:1113-1123, 1996.
47. Friedlander P, Haupt Y, Prives C, Oren M. A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol Cell Biol 16:4961-4971, 1996.
48. Ludwig RL, Bates S, Vousden KH. Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function. Mol Cell Biol 16:4952-4960, 1996.
49. Brown K, Quintanilla M, Ramsden M, Kerr IB, Young S, Balmain A. v-ras genes from Harvey and BALB murine sarcoma viruses can act as initiators of two stage mouse skin carcinogenesis. Cell 46:447-456, 1986.
50. Ananthaswamy HN, Price JE, Goldberg LH, Bales ES. Detection and identification of activated oncogenes in human skin cancers occurring on sun-exposed body sites. Cancer Res 48:3341-3346, 1988.
51. Pierceall WE, Goldberg LH, Tainsky MA, Mukhopadhyay T, Ananthaswamy HN. Ras gene mutation and amplification in human nonmelanoma skin cancers. Mol Carcinog 4:196-202, 1991.
52. Spencer JM, Kahn SM, Jiang W, DeLeo VA, Weinstein IB. Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas. Arch Dermatol 131:796-800, 1995.
53. Daya-Grosjean L, Robert C, Drougard C, Suarez H, Sarasin A. High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xeroderma pigmentosum patients. Cancer Res 53:1625-1629, 1993.
54. Greenhalgh DA, Wang XJ, Donehower LA, Roop DR. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha. Cancer Res 56:4413-4423, 1996.